Non-cirrhotic portal-splenic-mesenteric vein thrombosis unmasking JAK2 V617F-positive polycythemia vera
Case report published in Clinical journal of gastroenterology (2026)
Abstract
Non-cirrhotic splanchnic venous thrombosis (SVT) can occur in myeloproliferative neoplasms. We report the case of a 69-year-old man who presented with a 2-week history of epigastric pain and was found to have simultaneous portal, splenic, and superior mesenteric vein thromboses in the absence of cirrhosis or malignancy on contrast-enhanced computed tomography. Laboratory testing revealed elevated haemoglobin/haematocrit with a low-normal mean corpuscular volume (83 fL), biochemical evidence of iron restriction, and an inappropriately low serum erythropoietin level. On further testing, JAK2 V617F was positive, and bone marrow findings supported the diagnosis of polycythemia vera (PV). This presentation is compatible with an iron-deficiency-modified PV phenotype (sometimes referred to as "masked PV"), in which iron restriction can attenuate or obscure typical erythrocytosis, and extensive non-cirrhotic SVT effectively unmasked the underlying clonal disorder. Edoxaban 30 mg once daily (body weight < 60 kg) was initiated without interruption or bleeding, and therapeutic phlebotomy was initiated to control the hematocrit. Follow-up computed tomography on day 78 demonstrated marked thrombus reduction with partial re-opacification of the main portal vein, and the patient continued to have a stable clinical course. This case highlights triple-site, non-cirrhotic SVT as a potential presenting feature of PV and supports early JAK2 V617F and erythropoietin testing, coupled with parallel anticoagulation and PV-directed management, in unexplained non-cirrhotic SVT.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Non-cirrhotic splanchnic venous thrombosis (SVT) can occur in myeloproliferative neoplasms.
Por qué esto importa para la hirudoterapia
Este informe de caso único describe a un hombre de 69 años con trombosis simultáneas de vena portal, esplénica y mesentérica superior no cirróticas que finalmente desveló una policitemia vera con mutación V617F de JAK2 (un fenotipo enmascarado 'modificado por deficiencia de hierro'), manejada con el anticoagulante oral edoxaban más flebotomía terapéutica, con reducción marcada del trombo para el día 78. Para la ASH, la conexión es temática únicamente -- documenta trombosis venosa esplénica extensa y el papel de la anticoagulación sistémica en su resolución, el mismo espacio de problemas de carga de trombo en el que se estudian los anticoagulantes derivados de sanguijuelas como puntos de partida para el descubrimiento de fármacos. Cautela honesta: un caso anecdótico único que utiliza un anticoagulante farmacéutico y flebotomía no tiene peso estadístico, no menciona sanguijuelas ni hirudoterapia, y no puede respaldar ninguna inferencia sobre el tratamiento basado en sanguijuelas.
Citación
Non-cirrhotic portal-splenic-mesenteric vein thrombosis unmasking JAK2 V617F-positive polycythemia vera.
Otake T et al. · Clinical journal of gastroenterology, 2026
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026